Press Releases

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that HOOKIPA has made strong progress in its collaboration with Gilead for novel arenavirus-based therapeutics intended to support functional cures for chronic Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections. HOOKIPA and Gilead Sciences designed and tested multiple arenaviral vect

Antabio SAS, the biopharmaceutical company focused on developing a broad pipeline of  antibacterial treatments against life threatening WHO critical priority pathogens, announces today that it has been awarded up to $4.4 million in a second tranche funding from CARB-X, the global non-profit partnership dedicated to tackling the global rising threat of drug-resistant bacteria. The funding is to support the development of Antabio's novel small molecule candidate for the treatment of Ps